Skip to main content
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1969 Feb;53(2):101–109. doi: 10.1136/bjo.53.2.101

Ophthalmological safety of chloroquine.

S P Percival, J Behrman
PMCID: PMC1207141  PMID: 5773461

Full text

PDF
101

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braley A. E. Dystrophy of the macula. Am J Ophthalmol. 1966 Jan;61(1):1–24. doi: 10.1016/0002-9394(66)90741-0. [DOI] [PubMed] [Google Scholar]
  2. Burns R. P. Delayed onset of chloroquine retinopathy. N Engl J Med. 1966 Sep 29;275(13):693–696. doi: 10.1056/NEJM196609292751303. [DOI] [PubMed] [Google Scholar]
  3. Carr R. E., Gouras P., Gunkel R. D. Chloroquine retinopathy. Early detection by retinal threshold test. Arch Ophthalmol. 1966 Feb;75(2):171–178. doi: 10.1001/archopht.1966.00970050173005. [DOI] [PubMed] [Google Scholar]
  4. FREEDMAN A., STEINBERG V. L. Chloroquine in rheumatoid arthritis; a double blindfold trial of treatment for one year. Ann Rheum Dis. 1960 Sep;19:243–250. doi: 10.1136/ard.19.3.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gunkel R. D. Retinal profiles. A psychophysical test of rod and cone sensitivity. Arch Ophthalmol. 1967 Jan;77(1):22–25. doi: 10.1001/archopht.1967.00980020024006. [DOI] [PubMed] [Google Scholar]
  6. KENNEDY C. B., O'QUINN S. E., HENINGTON V. M., PERRET W. J. Chloroquine: therapeutic indications and side effects. South Med J. 1963 Jul;56:760–764. doi: 10.1097/00007611-196307000-00011. [DOI] [PubMed] [Google Scholar]
  7. Kersley G. D. An assessment of antimalarials in the treatment of the connective tissue diseases. Practitioner. 1966 Jul;197(177):57–59. [PubMed] [Google Scholar]
  8. NEUMANN E., ZAUBERMAN H. GLAUCOMA SURVEY IN LIBERIA. Am J Ophthalmol. 1965 Jan;59:8–12. doi: 10.1016/0002-9394(65)95010-5. [DOI] [PubMed] [Google Scholar]
  9. OKUN E., GOURAS P., BERNSTEIN H., VON SALLMANN L. Chloroquine retinopathy; a report of eight cases with ERG and dark-adaptation findings. Arch Ophthalmol. 1963 Jan;69:59–71. doi: 10.1001/archopht.1963.00960040065013. [DOI] [PubMed] [Google Scholar]
  10. PENNER R., SOMERS K. Bilateral macular degeneration associated with chloroquine therapy. Am J Ophthalmol. 1962 Sep;54:381–385. doi: 10.1016/0002-9394(62)93754-6. [DOI] [PubMed] [Google Scholar]
  11. Percival S. P., Meanock I. Chloroquine: ophthalmological safety, and clinical assessment in rheumatoid arthritis. Br Med J. 1968 Sep 7;3(5618):579–584. doi: 10.1136/bmj.3.5618.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. REES R. B., MAIBACH H. I. CHLOROQUINE. A REVIEW OF REACTIONS AND DERMATOLOGIC INDICATIONS. Arch Dermatol. 1963 Sep;88:280–289. doi: 10.1001/archderm.1963.01590210038006. [DOI] [PubMed] [Google Scholar]
  13. Ruben M. Some intolerances from corneal contact lenses; and a report upon high refractive error cases fitted. Trans Ophthalmol Soc U K. 1964;84:15–28. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES